News

SelectQuote Investors Urged to Take Action Before Deadline

SelectQuote Investors Urged to Take Action Before Deadline

SelectQuote Investors Urged to Take Action Before Deadline

In an important reminder for investors, Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is calling upon individuals who have incurred losses exceeding $100,000 in SelectQuote, Inc. (NYSE: SLQT) to take action. They need to file their lead plaintiff applications for a class action lawsuit before the designated deadline. Investors who purchased SelectQuote's securities during the class period from September 9, 2020, to May 1, 2025, must act quickly to ensure their legal rights are protected.

Important Deadline Approaches

Key Dates

The cut-off date for filing a lead plaintiff application is October 10, 2025. This enforcement comes following serious allegations against SelectQuote regarding violations of securities laws, including failing to disclose critical information impacting investors.

Investors who have been affected by these developments are strongly encouraged to discuss their legal options. KSF Managing Partner Lewis Kahn is available for consultation, allowing investors to understand the implications of these claims and potential recovery for their losses.

Details of the Lawsuit

The lawsuit alleges that SelectQuote and its executives did not inform investors about significant issues affecting the company. This includes accusations from the U.S. Department of Justice regarding the receipt of illegal kickbacks from health insurers in exchange for directing Medicare beneficiaries towards specific plans. Such practices raised ethical questions, illustrating a potential conspiracy against customers deemed less profitable.

Major Allegations

According to the allegations, SelectQuote purportedly participated in discriminatory practices against individuals with disabilities. Furthermore, investors learned that the company misled them by claiming to provide unbiased coverage comparisons, when, in reality, they reportedly directed clients to plans based solely on financial incentives rather than quality.

Impact on Share Price

Following the revelations leading to the lawsuit, SelectQuote's share price significantly dropped by 19.2% to close at $2.56 per share on May 1, 2025. This dip underscores the financial ramifications these allegations can have on both the company and its investors. The volume of trading during this period was notably high, suggesting a strong reaction from the market in response to the news.

About Kahn Swick & Foti, LLC

As a respected firm within the securities litigation landscape, Kahn Swick & Foti, LLC has established a reputation for advocating on behalf of shareholders. They specialize in corporate fraud, working diligently to secure recoveries for investors impacted by mismanagement and unethical company practices. With offices in multiple locations, they provide accessible legal support for clients across the nation.

The firm recently achieved recognition as one of the top ten firms in the country based on total settlement value, reflecting their commitment to achieving justice for investors.

Get in Touch

Investors wishing to consult with KSF can reach out to Lewis Kahn directly at 1-877-515-1850 or through email. They can also visit the firm's website to learn more about ongoing class actions and how to navigate their options amid these legal challenges.

Frequently Asked Questions

What is SelectQuote, Inc.?

SelectQuote, Inc. is a company focused on providing consumers with insurance quote comparisons, primarily in the health insurance sector.

What is the lawsuit about?

The lawsuit addresses allegations against SelectQuote for securities fraud, including failing to disclose important business practices affecting their financial health.

How can I join the class action lawsuit?

To participate, investors must file a lead plaintiff application by the deadline of October 10, 2025.

Who can help me with my claim?

Kahn Swick & Foti, LLC offers support for affected investors, providing legal advice and assistance in filing claims.

What should I do if I lost money in SelectQuote?

If you have incurred significant losses, it’s advisable to reach out to a legal expert to explore your options regarding recovery through the ongoing class action lawsuit.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

PotlatchDeltic Reveals Tax Implications for 2024 Shareholder Dividends

Updated Category News Views 247

PotlatchDeltic Reveals Dividend Tax Treatment for 2024 PotlatchDeltic Corporation (Nasdaq: PCH) is stepping into the spotlight by announcing the tax treatment for its anticipated dividend distributions throughout the year. As a prominent player in the real estate investment sector, this announcement brings clarity to investors regarding how dividends will be categorized...

Continue Reading
Beyond Air Secures $3.25 Million from Warrant Exercises

Updated Category News Views 158

Beyond Air's Strategic Moves to Boost Capital Beyond Air, Inc. (NASDAQ: XAIR), a leading medical device and biopharmaceutical company, is making waves in the financial realm. Focused on the innovative use of nitric oxide (NO) to enhance patient care, Beyond Air has announced the immediate exercise of certain outstanding warrants, aiming to generate approximately $3.25...

Continue Reading
Dr. Sven Kili Joins Saisei Ventures as New Partner

Updated Category News Views 194

Saisei Ventures Welcomes Dr. Sven Kili as Partner Saisei Ventures, a prominent investment firm focused on the advancement of biotechnology and therapeutic innovations, has announced an exciting new chapter in its journey. Dr. Sven Kili, MD, has been appointed as a partner, marking a significant addition to the team's leadership. Dr. Kili, who played an advisory role since...

Continue Reading
MangoRx Unveils Innovative Tirzepatide Tablet for Weight Loss

Updated Category News Views 192

Mangoceuticals, Inc. (NASDAQ: MGRX) launched its new oral Tirzepatide tablet, TRIM, back in 2024 at a steep price of $399 per month. Traders noticed this shift towards a convenient alternative to traditional injectables and were already debating the long-term implications on sales and market share. TRIM's Role: A Game Changer for Weight Management? Tirzepatide has made...

Continue Reading
Mama’s Creations Q2 FY2025 Earnings Call Announcement

Updated Category News Views 77

Mama’s Creations to Host Earnings Call for Second Quarter FY2025 Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, is preparing to announce its financial results for the fiscal second quarter, which ended on July 31. The earnings call is scheduled to take place after the market closes on September 10....

Continue Reading